Bavarian Nordic Transactions In Connection With Share Buy-Back Program
| Number of shares | Average purchase price, DKK | Transaction value, DKK | |
| March 12, 2026 | 34,100 | 177.19 | 6,042,217 |
| March 13, 2026 | 5,986 | 176.94 | 1,059,173 |
| Accumulated under the program | 40,086 | 177.15 | 7,101,390 |
The details for each transaction made under the share repurchase program are published on bavarian-nordic.
Following these transactions and adjusted for the transfer of shares to current and former members of the Executive Management related to the vesting of restricted stock units on March 12, 2026, Bavarian Nordic holds a total of 1,737,847 treasury shares, corresponding to 2.19 % of the Company's share capital.
About Bavarian Nordic
Bavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and have a leading portfolio of travel vaccines. For more information, visit
Forward-looking statements
This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. All such forward-looking statements are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. We undertake no obligation to publicly
Contact investors:
Europe: Disa Tuominen, IR Manager, ...
US: Graham Morrell, Gilmartin Group, ..., Tel: +1 781 686 9600
Contact media:
Nicole Seroff, Vice President Corporate Communications, ..., Tel: +45 53 88 06 03
Company Announcement no. 12 / 2026
Attachments
-
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Appendix with detailed transaction data
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment